Finance ❯ Mergers and Acquisitions

Valuation

Market Trends Market Impact Stock Prices Sports Teams Share Prices Market Share Debt Management Investment Funds Cash Deals Underdog

Jazz Pharmaceuticals to Buy Actio Biosciences for $820 Million

The deal strengthens Jazz’s rare-epilepsy pipeline by adding ABS-1230, an oral precision therapy now in a Phase Ib/IIa registrational trial.

Adam Schefter Confirmed as Early Investor in Underdog Sale to IG Group

Rocket Lab to Buy Iridium for About $8 Billion

Lilly to Acquire Centessa for $6.3 Billion to Add Orexin Sleep Drugs

Murdoch Family Reaches $3.3 Billion Settlement to Cement Lachlan Murdoch’s Control Through 2050

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion

Sanofi to Acquire Blueprint Medicines for $9.1 Billion, Boosting Its Rare Immunology Pipeline

Hailey Bieber Sells Rhode to e.l.f. Beauty for Up to $1 Billion

Paul Marshall Buys The Spectator for £100 Million